EFPIA - NEWSLETTER

EFPIA Newsletter 30 November 2017

#WeWontRest guest blog

A life as normal as possible for people living with Diabetes

A guest blog by Beate Kretschmer, Director Market Access at Lilly Germany

Latest estimates show that over 60 million Europeans live with diabetes. In Germany, this holds true for about 7.5 million people – with a rising tendency. As people are being diagnosed with diabetes at an increasingly younger age, in Germany alone, over 2 million patients with the chronic condition are of working age. This is why we are committed to improve the conditions for people living and working with diabetes.

News

28 November 2017 28112017 Europe’s life science industry urges the UK and EU27 to safeguard patients’ access...

Even in the context of the Brexit negotiations where all sectors are looking for clarity on the future, it’s important...

29 November 2017 29112017 European Commission launches: “What I need to know about Biosimilar Medicines - Information...

Today the European Commission launched the translations of the Q&A paper: “What I need to know about Biosimilar Medicines...

Blogs

24 November 2017 24112017 Incentives, IP and smaller companies; case story: Transgene

IP rights and EU pharmaceutical incentives enable innovation for the cures of tomorrow

29 November 2017 29112017 EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing...

Making research data available to qualified researchers has the great potential to advance medical research to benefit...

Documents

Report on the 2016 Member Company Survey on the EFPIA-PhRMA Principles for Responsible Clinical... 29 November 2017 (Publications)

The biopharmaceutical industry believes that the disclosure of clinical trial results and appropriate sharing of clinical...

What we are reading

Cancer, neurodegenerative disease and medicines safety feature in new IMI Call for proposals... 01 December 2017 (IMI)

UK and pharma industry call for transition period for medicines supply 29 November 2017 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶